Testing effectiveness (Phase 2)Ended earlyNCT00329537What this trial is testingStudy of Sargramostim in Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Genzyme, a Sanofi Company 11
Large-scale testing (Phase 3)Study completedNCT01917019What this trial is testingA Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisWho this might be right forMultiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more Biogen 101
Large-scale testing (Phase 3)Study completedNCT04172441What this trial is testingTrial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital HyperinsulinismWho this might be right forCongenital Hyperinsulinism Zealand Pharma 12
Testing effectiveness (Phase 2)Study completedNCT03340675What this trial is testingOral Ifetroban in Subjects With Duchenne Muscular DystrophyWho this might be right forDuchenne Muscular Dystrophy CardiomyopathyCardiomyopathy, Dilated Cumberland Pharmaceuticals 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217015What this trial is testingKT-621 Administered Orally to Participants With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Kymera Therapeutics, Inc. 200
Large-scale testing (Phase 3)Study completedNCT01484652What this trial is testingSafety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label ExtensionWho this might be right forPain, PostoperativeBunion Mallinckrodt 329
Early research (Phase 1)Study completedNCT04976855What this trial is testingStudy to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use DisorderWho this might be right forHealthy VolunteerOpioid-use Disorder Indivior Inc. 64
Early research (Phase 1)Study completedNCT00533585What this trial is testingBAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT07377656What this trial is testingStrengthening HPV Immunization Through EPI Leveraged DeliveryWho this might be right forHPV Vaccine International Vaccine Institute 115
Testing effectiveness (Phase 2)Ended earlyNCT05351554What this trial is testingAssess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac SarcoidosisWho this might be right forSarcoidosis, Cardiac Kinevant Sciences GmbH 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239What this trial is testingTibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Who this might be right forSystemic Sclerosis (SSc)Scleroderma Zura Bio Inc 80
Early research (Phase 1)Study completedNCT01348737What this trial is testingAssessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy VolunteersWho this might be right forAlzheimer's DiseaseSafetyTolerability+2 more AstraZeneca 72
Large-scale testing (Phase 3)Looking for participantsNCT06082037What this trial is testingTest How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionWho this might be right forLung Transplant Rejection Sanofi 180
Testing effectiveness (Phase 2)Study completedNCT03728634What this trial is testingEvaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).Who this might be right forHealthy VolunteershATTR Amyloidosis Ionis Pharmaceuticals, Inc. 47
Early research (Phase 1)Ended earlyNCT03618160What this trial is testingAssess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian ParticipantsWho this might be right forHealthy Janssen Pharmaceutical K.K. 42
Testing effectiveness (Phase 2)UnknownNCT05009680What this trial is testingA Single and Repeat Dose Trial in Participants With Hepatic ImpairmentWho this might be right forHepatic Impairment Galecto Biotech AB 54
Testing effectiveness (Phase 2)Study completedNCT01803074What this trial is testingStudy to Evaluate a HIV Drug for the Treatment of HIV InfectionWho this might be right forInfection, Human Immunodeficiency VirusHIV Infections ViiV Healthcare 107
Post-approval studies (Phase 4)Study completedNCT02794480What this trial is testingPhase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct UseWho this might be right forAsthma GlaxoSmithKline 324
Not applicableStudy completedNCT02522988What this trial is testingThe Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer SurvivorsWho this might be right forFatigue University of Alabama at Birmingham 74
Large-scale testing (Phase 3)Study completedNCT00531427What this trial is testingBuprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of KneeWho this might be right forChronic PainOsteoarthritis of the Knee Purdue Pharma LP 567